Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Tang

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor TrialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Blood Advances|June 3, 2024
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomesKevin T Nead, Taebeom Kim, LiJin Joo, et al.
Stem Cells (Dayton, Ohio)|June 11, 2017
Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived TeratomasAndrew S Lee, Chad Tang, Wan Xing Hong, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient CareMatthew S Ning, Daniel R Gomez, Aashish K Shah, et al.
Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinicChad Tang, Kenneth Hess, Denis Leonardo F Jardim, et al.
Clinical Breast Cancer|July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unitDebora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.
Brachytherapy|July 20, 2020
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapyDavid Boyce-Fappiano, Tharakeswara K Bathala, Rong Ye, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor TrialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Blood Advances|June 3, 2024
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomesKevin T Nead, Taebeom Kim, LiJin Joo, et al.
Stem Cells (Dayton, Ohio)|June 11, 2017
Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived TeratomasAndrew S Lee, Chad Tang, Wan Xing Hong, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient CareMatthew S Ning, Daniel R Gomez, Aashish K Shah, et al.
Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinicChad Tang, Kenneth Hess, Denis Leonardo F Jardim, et al.
Clinical Breast Cancer|July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unitDebora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.
Brachytherapy|July 20, 2020
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapyDavid Boyce-Fappiano, Tharakeswara K Bathala, Rong Ye, et al.
Pageof 23